Cover Image
市場調查報告書

POC (照護現場) 分析設備的全球市場:醫療設備的開發平台評估

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 363398
出版日期 內容資訊 英文 130 Pages
訂單完成後即時交付
價格
Back to Top
POC (照護現場) 分析設備的全球市場:醫療設備的開發平台評估 Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月08日 內容資訊: 英文 130 Pages
簡介

面向 本報告提供全球POC (Point of Care:臨床現場) 分析設備的市場上的主要開發中產品與臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • POC分析設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • POC分析設備的企業:各臨床實驗階段的開發中產品
  • POC分析設備:各臨床實驗階段的開發中產品

第5章 POC分析設備市場:企業、產品概要

  • Akers Biosciences, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Akonni Biosystems, Inc.
  • ApoCell, Inc.
  • Attophotonics Biosciences GmbH
  • Bio-Alternative Medical Devices Ltd
  • BioDirection, Inc.
  • BioMedomics, Inc
  • bioMerieux S.A.
  • Biopico Systems Inc.
  • Boston University
  • Cepheid
  • Co-Diagnostics HBDC, Inc.
  • Indian Institute of Technology, Madras
  • John Hopkins University
  • Magna Diagnostics GmbH
  • McKesson Corporation
  • Nanomix, Inc.
  • OncoGenesis
  • Phoenix Biosystems Inc
  • PositiveID Corporation
  • Quanterix Corporation
  • Radisens Diagnostics Limited
  • Rapid Biosensor Systems
  • SenGenix, Inc.
  • Thermal Gradient, Inc.
  • University of Alberta
  • University of California, Berkeley
  • University of California, Davis
  • Wellstat Diagnostics, LLC
  • Xen Biofluidx Inc

第6章 POC分析設備市場:目前的趨勢 (共3件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0433EPD

GlobalData's Medical Devices sector report, "Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 6
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Point-of-Care (POC) Analyzers Overview 10

3 Products under Development 11

  • 3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
  • 3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
  • 3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
  • 3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
  • 3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 16

  • 4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
  • 4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18

5 Point-of-Care (POC) Analyzers Companies and Product Overview 20

  • 5.1 Akers Biosciences Inc Company Overview 20
    • 5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Akonni Biosystems Inc Company Overview 22
    • 5.2.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Alere Inc Company Overview 23
    • 5.3.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.4 Amplino B.V. Company Overview 24
    • 5.4.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 Analytical Diagnostic Solutions Inc Company Overview 25
    • 5.5.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.6 ApoCell Inc Company Overview 26
    • 5.6.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.7 Aquila Diagnostic Systems Inc. Company Overview 27
    • 5.7.1 Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.8 Atonomics A/S Company Overview 28
    • 5.8.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.9 Attophotonics Biosciences GmbH Company Overview 29
    • 5.9.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.10 Beckman Coulter Inc Company Overview 30
    • 5.10.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 Binghamton University Company Overview 31
    • 5.11.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.12 Bio-Alternative Medical Devices Ltd Company Overview 32
    • 5.12.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 BioMedomics Inc Company Overview 33
    • 5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.14 bioMerieux S.A. Company Overview 35
    • 5.14.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.15 Biopico Systems Inc. Company Overview 36
    • 5.15.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.16 Boston University Company Overview 37
    • 5.16.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.17 CardioGenics Inc Company Overview 39
    • 5.17.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.18 Cepheid Company Overview 40
    • 5.18.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.19 ChipCare Corp Company Overview 44
    • 5.19.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.20 City, University of London Company Overview 45
    • 5.20.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.21 Co-Diagnostics HBDC, Inc. Company Overview 46
    • 5.21.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.22 Exosome Diagnostics Inc Company Overview 47
    • 5.22.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.23 Florida International University Company Overview 48
    • 5.23.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.24 Indian Institute of Technology Madras Company Overview 49
    • 5.24.1 Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.25 Indiana University Company Overview 50
    • 5.25.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.26 Magna Diagnostics GmbH Company Overview 51
    • 5.26.1 Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.27 Maxygen-mobile DNA tests Company Overview 52
    • 5.27.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.28 mBio Diagnostics Inc Company Overview 53
    • 5.28.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.29 McKesson Corp Company Overview 54
    • 5.29.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.30 MML Ltd Company Overview 55
    • 5.30.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.31 Molbio Diagnostics Pvt. Ltd. Company Overview 56
    • 5.31.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.32 Molecular Warehouse Ltd Company Overview 57
    • 5.32.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.33 Mologic Ltd Company Overview 58
    • 5.33.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.34 Nalia Systems Ltd Company Overview 59
    • 5.34.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.35 Newcastle University Company Overview 60
    • 5.35.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.36 Ohmx Corp Company Overview 61
    • 5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.37 OncoGenesis Company Overview 62
    • 5.37.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.38 Pacific Nanoscience, Inc. Company Overview 63
    • 5.38.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.39 Parallax Health Sciences, Inc. Company Overview 64
    • 5.39.1 Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.40 Phoenix Biosystems Inc Company Overview 65
    • 5.40.1 Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.41 POC Medical Systems Inc. Company Overview 66
    • 5.41.1 POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.42 Pocared Diagnostics Ltd. Company Overview 67
    • 5.42.1 Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.43 PositiveID Corp Company Overview 68
    • 5.43.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.44 Quanterix Corp Company Overview 70
    • 5.44.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.45 Radisens Diagnostics Ltd Company Overview 71
    • 5.45.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.46 SenGenix Inc Company Overview 72
    • 5.46.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.47 Thermal Gradient Inc Company Overview 73
    • 5.47.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.48 Trinity Biotech Plc Company Overview 75
    • 5.48.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.49 Two Pore Guys Inc Company Overview 76
    • 5.49.1 Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.50 University of California Berkeley Company Overview 77
    • 5.50.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.51 ViroCyt Inc Company Overview 80
    • 5.51.1 ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.52 Wellstat Diagnostics LLC Company Overview 81
    • 5.52.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81

6 Point-of-Care (POC) Analyzers- Recent Developments 82

  • 6.1 Aug 30, 2017: PositiveID's ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018 82
  • 6.2 Aug 30, 2017: bioMerieux - First-Half 2017 Results 83
  • 6.3 Aug 16, 2017: Two Pore Guys Announces Positive Results from Pilot Point-of-Care Liquid Biopsy Study with UCSF 86
  • 6.4 Aug 08, 2017: PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System 87
  • 6.5 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results 88
  • 6.6 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 89
  • 6.7 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 92
  • 6.8 Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 93
  • 6.9 Jun 21, 2017: Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC 94
  • 6.10 Jun 15, 2017: Zenosense: Issuance of U.S. MIDS Patent 94
  • 6.11 May 31, 2017: Exosome Diagnostics Will Demonstrate the "Shahky" Point of Care Protein Detection Instrument at American Society for Clinical Oncology 95
  • 6.12 May 24, 2017: PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market 96
  • 6.13 May 18, 2017: McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results 96
  • 6.14 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 99
  • 6.15 Mar 02, 2017: McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company 102
  • 6.16 Feb 16, 2017: New study reaffirms Quo-Test A1c meets IFCC performance criteria 103
  • 6.17 Feb 03, 2017: Exosome Diagnostics Announces Early Access Program for "Shahky" - Exosome Protein Interrogation Instrument 104
  • 6.18 Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 105
  • 6.19 Jan 25, 2017: McKesson Reports Fiscal 2017 Third-Quarter Results 106
  • 6.20 Jan 23, 2017: Zenosense: New Patent Application for Additional MIDS Detection Method 108
  • 6.21 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 109
  • 6.22 Jan 17, 2017: McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims 112
  • 6.23 Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument 113
  • 6.24 Jan 05, 2017: McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare 113
  • 6.25 Jan 04, 2017: Exosome Diagnostics Runs World's First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital 114
  • 6.26 Dec 28, 2016: McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada 115
  • 6.27 Dec 21, 2016: McKesson and Change Healthcare Announce Termination off Hart-Scott-Rodino Act Waiting Period for the Creation of a New Healthcare Information Technology Company 116
  • 6.28 Dec 08, 2016: Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy 116
  • 6.29 Nov 29, 2016: Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics System 117
  • 6.30 Nov 15, 2016: PositiveID to Exhibit Firefly Dx System at the AMSUS Federal Health 2016 Conference 117
  • 6.31 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 117
  • 6.32 Oct 31, 2016: Zenosense MIDS Cardiac Bench Reader Development 118
  • 6.33 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook 118
  • 6.34 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report 120
  • 6.35 Oct 20, 2016: ViroCyt Develops Rapid Detection System For Enterovirus 71 121
  • 6.36 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 122
  • 6.37 Oct 04, 2016: Trinity Biotech Announces FDA 510(k) Submission withdrawal for Meritas Point of Care Analyzer 124
  • 6.38 Sep 19, 2016: Zenosense General Update - Cardiac Device Development 125

7 Appendix 127

  • 7.1 Methodology 127
  • 7.2 About GlobalData 130
  • 7.3 Contact Us 130
  • 7.4 Disclaimer 130

List of Tables

1.1 List of Tables

  • Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
  • Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
  • Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
  • Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
  • Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
  • Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
  • Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18
  • Table 8: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 9: minDNAnalyzer - Product Status 20
  • Table 10: minDNAnalyzer - Product Description 21
  • Table 11: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 12: TruDx 2000 Platform - Product Status 22
  • Table 13: TruDx 2000 Platform - Product Description 22
  • Table 14: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 15: Clondiag HIV Molecular Device - Product Status 23
  • Table 16: Clondiag HIV Molecular Device - Product Description 23
  • Table 17: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 18: Scout PCR Analyzer - Product Status 24
  • Table 19: Scout PCR Analyzer - Product Description 24
  • Table 20: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 21: POC Device - Malaria - Product Status 25
  • Table 22: POC Device - Malaria - Product Description 25
  • Table 23: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 24: ApoStream System - Product Status 26
  • Table 25: ApoStream System - Product Description 26
  • Table 26: Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 27: Accutas Malaria Diagnostic System - Product Status 27
  • Table 28: Accutas Malaria Diagnostic System - Product Description 27
  • Table 29: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 30: Atolyzer PoC - Product Status 28
  • Table 31: Atolyzer PoC - Product Description 28
  • Table 32: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 33: Nanoparticle Microfluidic Color Device - Product Status 29
  • Table 34: Nanoparticle Microfluidic Color Device - Product Description 29
  • Table 35: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 36: DxN VERIS MDx System - Product Status 30
  • Table 37: DxN VERIS MDx System - Product Description 30
  • Table 38: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 39: U-PAC - Product Status 31
  • Table 40: U-PAC - Product Description 31
  • Table 41: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 42: Magnetic Immunoassay Detection System - Product Status 32
  • Table 43: Magnetic Immunoassay Detection System - Product Description 32
  • Table 44: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 45: Next Generation Ultra-sensitive Nanotube Platform - Product Status 33
  • Table 46: Next Generation Ultra-sensitive Nanotube Platform - Product Description 33
  • Table 47: TR-LFIA Diagnostic Platform - Product Status 34
  • Table 48: TR-LFIA Diagnostic Platform - Product Description 34
  • Table 49: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 50: Magnotech System - Product Status 35
  • Table 51: Magnotech System - Product Description 35
  • Table 52: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 53: MONITOR System - Product Status 36
  • Table 54: MONITOR System - Product Description 36
  • Table 55: Boston University Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 56: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status 37
  • Table 57: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description 37
  • Table 58: Point-Of-Care Device - Allergen-Specific IgE - Product Status 38
  • Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Description 38
  • Table 60: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 61: QL Care Analyzer - Product Status 39
  • Table 62: QL Care Analyzer - Product Description 39
  • Table 63: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 64: GeneXpert Omni - Product Status 40
  • Table 65: GeneXpert Omni - Product Description 40
  • Table 66: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status 41
  • Table 67: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description 41
  • Table 68: Cepheid - Ongoing Clinical Trials Overview 42
  • Table 69: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 43
  • Table 70: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 71: Polyvalent Analyzer (PAx) - Product Status 44
  • Table 72: Polyvalent Analyzer (PAx) - Product Description 44
  • Table 73: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 74: POC Device - Mood Disorders - Product Status 45
  • Table 75: POC Device - Mood Disorders - Product Description 45
  • Table 76: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 77: LightPCR - Product Status 46
  • Table 78: LightPCR - Product Description 46
  • Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 80: Shahky - Product Status 47
  • Table 81: Shahky - Product Description 47
  • Table 82: Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 83: Cortisol Detector - Product Status 48
  • Table 84: Cortisol Detector - Product Description 48
  • Table 85: Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 86: Microfluidic Flow Analyzer - Product Status 49
  • Table 87: Microfluidic Flow Analyzer - Product Description 49
  • Table 88: Indiana University Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 89: Microfluidic Device - Cancer - Product Status 50
  • Table 90: Microfluidic Device - Cancer - Product Description 50
  • Table 91: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 92: MAZER System - Product Status 51
  • Table 93: MAZER System - Product Description 51
  • Table 94: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 95: Maxygen POC Device - Product Status 52
  • Table 96: Maxygen POC Device - Product Description 52
  • Table 97: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 98: MBio CD4 System - Product Status 53
  • Table 99: MBio CD4 System - Product Description 53
  • Table 100: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 101: Proventys PDx System - Product Status 54
  • Table 102: Proventys PDx System - Product Description 54
  • Table 103: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 104: MIDS Cardiac - Product Status 55
  • Table 105: MIDS Cardiac - Product Description 55
  • Table 106: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 107: Truelab Quattro Analyzer - Product Status 56
  • Table 108: Truelab Quattro Analyzer - Product Description 56
  • Table 109: Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 110: Portable Biosensor Device - Product Status 57
  • Table 111: Portable Biosensor Device - Product Description 57
  • Table 112: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 113: ACuTEGA - Product Status 58
  • Table 114: ACuTEGA - Product Description 58
  • Table 115: Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 116: NALIA Single-Patient Point-Of-Care Device - Product Status 59
  • Table 117: NALIA Single-Patient Point-Of-Care Device - Product Description 59
  • Table 118: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 119: SmartHEALTH POC System - Colorectal Cancer - Product Status 60
  • Table 120: SmartHEALTH POC System - Colorectal Cancer - Product Description 60
  • Table 121: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 122: Handheld Clinical Analyzer - Product Status 61
  • Table 123: Handheld Clinical Analyzer - Product Description 61
  • Table 124: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 125: Genesis Point-Of-Care Diagnostic System - Product Status 62
  • Table 126: Genesis Point-Of-Care Diagnostic System - Product Description 62
  • Table 127: Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 128: Nanomonitor - Product Status 63
  • Table 129: Nanomonitor - Product Description 63
  • Table 130: Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 131: SPARKS Mobile - Product Status 64
  • Table 132: SPARKS Mobile - Product Description 64
  • Table 133: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 134: Point of Care HIV Combo Device - Product Status 65
  • Table 135: Point of Care HIV Combo Device - Product Description 65
  • Table 136: POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 137: Pandora CDx Point-of-Care System - Product Status 66
  • Table 138: Pandora CDx Point-of-Care System - Product Description 66
  • Table 139: Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 140: POCARED P-1000 - Product Status 67
  • Table 141: POCARED P-1000 - Product Description 67
  • Table 142: PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 143: Firefly Dx System - Product Status 68
  • Table 144: Firefly Dx System - Product Description 69
  • Table 145: Firefly Dx System - Zika Virus - Product Status 69
  • Table 146: Firefly Dx System - Zika Virus - Product Description 69
  • Table 147: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 148: Simoa 5.0 - Product Status 70
  • Table 149: Simoa 5.0 - Product Description 70
  • Table 150: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 151: Radisens Instrument - Product Status 71
  • Table 152: Radisens Instrument - Product Description 71
  • Table 153: SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 154: SenGenix Strips And Reader System - Product Status 72
  • Table 155: SenGenix Strips And Reader System - Product Description 72
  • Table 156: Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 157: FlashDirect-HC - Product Status 73
  • Table 158: FlashDirect-HC - Product Description 73
  • Table 159: FlashDirect-LC - Product Status 74
  • Table 160: FlashDirect-LC - Product Description 74
  • Table 161: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 162: Meritas Point of Care Analyzer - Product Status 75
  • Table 163: Meritas Point of Care Analyzer - Product Description 75
  • Table 164: Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 165: Handheld Nanopore Based Device - Cancer - Product Status 76
  • Table 166: Handheld Nanopore Based Device - Cancer - Product Description 76
  • Table 167: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 168: Microfluidic Blotting Device - Product Status 77
  • Table 169: Microfluidic Blotting Device - Product Description 77
  • Table 170: Mobile Molecular Diagnostics System - Product Status 78
  • Table 171: Mobile Molecular Diagnostics System - Product Description 78
  • Table 172: Multi-dimensional Microfluidic Device - Product Status 78
  • Table 173: Multi-dimensional Microfluidic Device - Product Description 78
  • Table 174: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Status 79
  • Table 175: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Description 79
  • Table 176: ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 177: ViroTag EV71 - Product Status 80
  • Table 178: ViroTag EV71 - Product Description 80
  • Table 179: Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 180: Electrochemiluminescent Based RNA Detection Platform - Product Status 81
  • Table 181: Electrochemiluminescent Based RNA Detection Platform - Product Description 81
  • Table 182: Glossary 129

List of Figures

1.2 List of Figures

  • Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
  • Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
  • Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
  • Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
  • Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
Back to Top